Search Results - "Powderly JD 2nd"

Proteomic Analysis Identifies Association of Periostin, a Matricellular Protein, with High Tumor Stroma and Immune Exclusion in Triple-Negative Breast Cancer.

Authors: Jeon, Yeonjin Lee, GunHee Jeong, Byung-Kwan et al.

Source: Cancer Research & Treatment. Jul2026, Vol. 58 Issue 3, p748-769. 22p.

The application of autologous cancer immunotherapies in the age of memory-NK cells.

Authors: Lizana-Vasquez GD Torres-Lugo M Dixon RB et al.

Source: Frontiers in immunology [Front Immunol] 2023 May 02; Vol. 14, pp. 1167666. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Induction of stress granules alleviates programmed cell death induced by lysosomal damage during NK cell cryopreservation.

Authors: Liu Y Liu X Wu G et al.

Source: Cell death discovery [Cell Death Discov] 2026 May 07; Vol. 12 (1). Date of Electronic Publication: 2026 May 07.

Publication Type: Journal Article

Journal Info: Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE

Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects.

Authors: Cao, Zhipeng Quazi, Sadia Arora, Sakshi et al.

Source: Journal of Biomedical Science. 1/9/2025, Vol. 32 Issue 1, p1-35. 35p.

Gatekeepers of immunity: mechanisms and regulation of immune checkpoints and their role in immune-privileged sites.

Authors: Abadi RNS Abadi ZNS Hooshmand S

Source: Molecular biology reports [Mol Biol Rep] 2025 Dec 18; Vol. 53 (1), pp. 206. Date of Electronic Publication: 2025 Dec 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Reidel Country of Publication: Netherlands NLM ID: 0403234 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4978 (Electronic) Linking ISSN: 03014851 NLM ISO Abbreviation: Mol Biol Rep Subsets: MEDLINE

LRRC superfamily expression in stromal cells predicts the clinical prognosis and platinum resistance of ovarian cancer.

Authors: Zhu, Xiaoying You, Shijing Du, Xiuzhen et al.

Source: BMC Medical Genomics. 1/18/2023, Vol. 16 Issue 1, p1-16. 16p.

First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors.

Authors: Gutierrez ME Tang SC Powderly JD 2nd et al.

Source: The oncologist [Oncologist] 2025 Jul 04; Vol. 30 (7).

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors.

Authors: Powderly JD 2nd Gutierrez ME Balmanoukian AS et al.

Source: The oncologist [Oncologist] 2025 Jul 04; Vol. 30 (7).

Publication Type: Journal Article; Clinical Trial, Phase I

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

PRDM1 Drives a TIM3+ Macrophage Immunosuppressive Niche via LGALS9 Signaling in Prostate Cancer Progression.

Authors: Zhang Y Mamtili I Chen Y et al.

Source: Oncology research [Oncol Res] 2026 Jun 16; Vol. 34 (7), pp. 26. Date of Electronic Publication: 2026 Jun 16 (Print Publication: 2026).

Publication Type: Journal Article

Journal Info: Publisher: Tech Science Press Country of Publication: United States NLM ID: 9208097 Publication Model: eCollection Cited Medium: Internet ISSN: 1555-3906 (Electronic) Linking ISSN: 09650407 NLM ISO Abbreviation: Oncol Res Subsets: MEDLINE; In Process

Advances and challenges in immunotherapy for advanced esophageal squamous cell carcinoma.

Authors: Wang Y Li H Zhao P et al.

Source: Frontiers in immunology [Front Immunol] 2026 Apr 10; Vol. 17, pp. 1739762. Date of Electronic Publication: 2026 Apr 10 (Print Publication: 2026).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Systemic strategies for osteosarcoma: advances and future directions.

Authors: Morya VK Magar AG Park SH et al.

Source: Discover oncology [Discov Oncol] 2025 Jul 18; Vol. 16 (1), pp. 1367. Date of Electronic Publication: 2025 Jul 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE

Advances in CAR-NK cell therapy for hematological malignancies.

Authors: Yang R Yang Y Liu R et al.

Source: Frontiers in immunology [Front Immunol] 2024 Jun 28; Vol. 15, pp. 1414264. Date of Electronic Publication: 2024 Jun 28 (Print Publication: 2024).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy.

Authors: Fantini M Arlen PM Tsang KY

Source: Frontiers in immunology [Front Immunol] 2023 Nov 24; Vol. 14, pp. 1275904. Date of Electronic Publication: 2023 Nov 24 (Print Publication: 2023).

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

The origins, roles and therapies of cancer associated fibroblast in liver cancer.

Authors: Zulaziz N Chai SJ Lim KP

Source: Frontiers in oncology [Front Oncol] 2023 Mar 23; Vol. 13, pp. 1151373. Date of Electronic Publication: 2023 Mar 23 (Print Publication: 2023).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models.

Authors: Anastasia A Formenti L Ostano P et al.

Source: Molecular oncology [Mol Oncol] 2025 Apr; Vol. 19 (4), pp. 1075-1091. Date of Electronic Publication: 2025 Feb 04.

Publication Type: Journal Article

Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Natural killer cell memory: challenges and opportunities for cancer immunotherapy.

Authors: Qu Y Zeng A Cheng Y et al.

Source: Cancer biology & therapy [Cancer Biol Ther] 2024 Dec 31; Vol. 25 (1), pp. 2376410. Date of Electronic Publication: 2024 Jul 10.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

Effector and cytolytic function of natural killer cells in anticancer immunity.

Authors: Karmakar S Mishra A Pal P et al.

Source: Journal of leukocyte biology [J Leukoc Biol] 2024 Jan 19; Vol. 115 (2), pp. 235-252.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 8405628 Publication Model: Print Cited Medium: Internet ISSN: 1938-3673 (Electronic) Linking ISSN: 07415400 NLM ISO Abbreviation: J Leukoc Biol Subsets: MEDLINE

Exploration of the antibody-drug conjugate clinical landscape.

Authors: Maecker H Jonnalagadda V Bhakta S et al.

Source: MAbs [MAbs] 2023 Jan-Dec; Vol. 15 (1), pp. 2229101.

Publication Type: Journal Article; Review

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101479829 Publication Model: Print Cited Medium: Internet ISSN: 1942-0870 (Electronic) Linking ISSN: 19420862 NLM ISO Abbreviation: MAbs Subsets: MEDLINE